PYPaul Yoon

Paul Yoon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Yoon has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Adriana Shen

    Keck School of Medicine of USC, Los Angeles, CA, United States

    1 shared publication
  • Albert J. Farias

    Keck School of Medicine of the University of Southern California, Los Angeles, CA

    1 shared publication
  • Alexandra J. Johns

    University of California Davis Medical Center Sacramento California USA

    1 shared publication
  • Anthony J. Sabo

    University of California Davis Medical Center Sacramento California USA

    1 shared publication
  • Brian T. Lee

    Digestive Health Institute, Hoag Memorial Hospital Presbyterian, Newport, CA, United States

    1 shared publication
  • Carol Y Ochoa-Dominguez

    Department of Population and Public Health Sciences, University of Southern California , Los Angeles, CA, USA

    1 shared publication

Latest Publications

  • Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis

    by Paul Yoon, Adriana Shen, Matthew Chen, Tara Foroohar, Isai Martinez Rios, Sade Brown, Jennifer L. Dodge, Brian T. Lee, Kali Zhou, Jeffrey Kahn, et al.


  • Open Access

    Black cancer patients navigating a health-care system of racial discrimination

    by Elleyse Garrett, Cindy Ma, Carol Y Ochoa-Dominguez, Stephanie Navarro, Paul Yoon, Chanita Hughes Halbert, Albert J Farias

    Background: Exposure to racial discrimination may exacerbate disparities throughout the cancer care continuum. Therefore, we explored how experiences of racial discrimination in the health-care setting manifest for Black cancer patients and how it contributes to racial disparities in cancer care. Methods: This qualitative analysis used semistructured in-depth interviews with Black cancer survivors not on active treatment from May 2019 to March 2020. All interviews were audio recorded, professionally transcribed, and uploaded into Dedoose software for analysis. We identified major themes and subthemes that highlight exposure to racial discrimination and its consequences for Black cancer patients when receiving cancer care. Results: Participants included 18 Black cancer survivors, aged 29-88 years. Most patients experienced racial discrimination when seeking care. Participants experienced racial discrimination from their interactions with health-care staff, medical assistants, front desk staff, and health insurance administrators. Exposure to overt racial discrimination in the health-care setting was rooted in racial stereotypes and manifested through verbal insults such as physicians using phrases such as “you people.” These experiences impacted the ability of the health-care delivery system to demonstrate trustworthiness. Patients noted “walking out” of their visit and not having their health issues addressed. Despite experiences with racial discrimination, patients still sought care out of necessity believing it was an inevitable part of the Black individual experience. Conclusion: We identified that exposure to racial discrimination in the health-care setting is pervasive, affects health-seeking behaviors, and degrades the patient–clinician relationship, which may likely contribute to racial disparities in cancer care.


  • Experience of a single academic institution with the National Accreditation Program for Rectal Cancer and the resulting improvement in care

    by Alexandra J. Johns, Paul S. Yoon, Anthony J. Sabo, Timothy T. Huynh, Diana L. Farmer, Shannon M. Navarro, Linda M. Farkas

    Aim: The American College of Surgeons Committee on Cancer developed the National Accreditation Program for Rectal Cancer (NAPRC) to reduce variations in rectal cancer care, standardize clinical practice and encourage multidisciplinary approaches. The aim of this study was to analyse if accreditation achieved a higher quality of care at one hospital.Method: The University of California Davis Medical Center was accredited in 2019. A retrospective review of rectal adenocarcinoma patients was performed between the years 2013 and 2018. Patients presenting from 2013 to 2015 were discussed at a gastrointestinal tumour board while patients in 2018 had an accredited rectal cancer tumour board. Patients from 2016 to 2017 were excluded as the programme was still developing. Compliance to the NAPRC standards was compared between the cohorts.Results: One hundred and thirty patients were evaluated, 88 (68%) in the prerectal tumour board cohort and 42 (32%) in the rectal tumour board cohort. The prerectal tumour board cohort often failed to meet attendance standards. All patients in the rectal tumour board cohort met all criteria. Similarly, clinical service compliance improved in the rectal tumour board cohort for 13 metrics, 10 of which were statistically significant. Although a high proportion of patients in both groups experienced quality surgery, i.e. complete total mesorectal excision and negative margins, the lack of complete pathological reporting in the prerectal tumour board cohort limited analysis.Conclusion: Multidisciplinary rectal cancer tumour boards are associated with improved compliance with recommended care by the NAPRC. Patients discussed at a rectal cancer tumour board were more likely to receive appropriate staging, coordinated care and have better clinical documentation.